The 4 analysts offering 12-month price forecasts for Evofem Biosciences Inc have a median target of 2.50, with a high estimate of 3.50 and a low estimate of 0.75. The median estimate represents a +212.50% increase from the last price of 0.80.
The current consensus among 4 polled investment analysts is to Buy stock in Evofem Biosciences Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$2.15
Reporting Date Nov 09
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.